Study of the effect of chronic kidney disease on the incidence of cardiovascular events in a native Spanish population

被引:0
|
作者
Cancho, Barbara [1 ]
Robles, Nicolas Roberto [1 ,2 ,3 ]
Felix-Redondo, Francisco Javier [4 ]
Lozano, Luis [5 ]
Fernandez-Berges, Daniel [6 ,7 ,8 ]
机构
[1] Hosp Univ Badajoz, Badajoz, Spain
[2] Univ Salamanca, Fac Med, Catedra Riesgo Vasc, Salamanca, Spain
[3] Inst Salud Carlos III RENINRED, Red Invest Renal, Madrid, Spain
[4] Ctr Salud Villanueva Serena Norte, Villanueva Serena, Badajoz, Spain
[5] Ctr Salud Merida, Badajoz, Spain
[6] Programa Invest Enfermedades Cardiovasc, Unidad Invest Don BenitoVillanueva Serena, Villanueva Serena, Badajoz, Spain
[7] Grp Invest Multidisciplinar Extremadura, Badajoz, Spain
[8] Inst Univ Invest Biosanitaria Extremadura IN, Badajoz, Spain
来源
MEDICINA CLINICA | 2021年 / 157卷 / 12期
关键词
Chronic kidney disease; Urinary albumin excretion; Cardiovascular disease; GLOMERULAR-FILTRATION-RATE; URINARY ALBUMIN EXCRETION; RISK; PREVALENCE; OUTCOMES; SPAIN; EPIDEMIOLOGY; DYSFUNCTION; MORTALITY; DEATH;
D O I
10.1016/j.medcli.2020.10.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: To evaluate the relationship between chronic kidney disease and the patient's cardiovascular risk measured through the incidence of major adverse cardiovascular events in a sample of Spanish population. Design and methods: The sample consisted of 2,668 subjects. Mean age was 50.6 +/- 14.5 years and 54.6% were female. In all, 3.5% of subjects had a glomerular filtration rate (GFR) below 60 ml/min and 4.3% a urinary albumin excretion (UAE) above 30 mg/g. GFR was estimated from serum creatinine using the CKD-EPI equation. UAE was measured in first morning urine sample as mg/g of creatinine. We examined the multivariable association between the estimated GFR and the risks of cardiovascular events and death. The median follow-up was 81 (75-89) months. Results: In CKD patients the hazard ratio (HR) was 1.36 (95% CI 0.97-1.91) (P = .079) for cardiovascu-lar events and 1.62 (95% CI 0.53-4.91) (P = .396) for cardiovascular mortality. Increased UAE was also associated with higher cardiovascular risk (HR 2.38; 95% CI 1.51-3.74; P < .001) as well as increased car-diovascular mortality (HR 4.78; 95% CI 2.50-9.11; P < .001). For patients with UAE between 30 and 300 mg/g HR for cardiovascular events was 2.09 (95% CI 1.34-3.50; P = .005) and 3.80 (95% CI 1.81-7.96; P < .001) for cardiovascular mortality. Conclusions: An independent association was found between reduced GFR and cardiovascular event inci-dence and mortality. Increased UAE showed a higher prognostic value than decreased GFR. Our findings highlight the clinical and public health importance of routinely measuring UAE. (C) 2021 Elsevier Espan tilde a, S.L.U. All rights reserved.
引用
收藏
页码:569 / 574
页数:6
相关论文
共 50 条
  • [41] Ambulatory blood pressure and cardiovascular events in chronic kidney disease
    Agarwal, Rajiv
    SEMINARS IN NEPHROLOGY, 2007, 27 (05) : 538 - 543
  • [42] Thyroid function and cardiovascular events in chronic kidney disease patients
    Afsar, Baris
    Yilmaz, Mahmut Ilker
    Siriopol, Dimitrie
    Unal, Hilmi Umut
    Saglam, Mutlu
    Karaman, Murat
    Gezer, Mustafa
    Sonmez, Alper
    Eyileten, Tayfun
    Aydin, Ibrahim
    Hamcan, Salih
    Oguz, Yusuf
    Covic, Adrian
    Kanbay, Mehmet
    JOURNAL OF NEPHROLOGY, 2017, 30 (02) : 235 - 242
  • [43] Peripheral Endothelial Function and Cardiovascular Events in Chronic Kidney Disease
    Hirata, Yoshihiro
    Sugiyama, Seigo
    Yamamoto, Eiichiro
    Matsuzawa, Yasushi
    Akiyama, Eiichi
    Kusaka, Hiroaki
    Fujisue, Koichiro
    Kurokawa, Hirofumi
    Matsubara, Junichi
    Sugamura, Koichi
    Maeda, Hirofumi
    Iwashita, Satomi
    Jinnouchi, Hideaki
    Matsui, Kunihiko
    Ogawa, Hisao
    CIRCULATION, 2013, 128 (22)
  • [44] Cardiovascular events in patients with deferred lesions and chronic kidney disease
    Takehiro Hata
    Hisao Otsuki
    Hiroyuki Arashi
    Masashi Nakao
    Junichi Yamaguchi
    Heart and Vessels, 2023, 38 : 1364 - 1370
  • [45] Inflammation and cardiovascular events in individuals with and without chronic kidney disease
    Weiner, D. E.
    Tighiouart, H.
    Elsayed, E. F.
    Griffith, J. L.
    Salem, D. N.
    Levey, A. S.
    Sarnak, M. J.
    KIDNEY INTERNATIONAL, 2008, 73 (12) : 1406 - 1412
  • [46] ApoM and Major Adverse Cardiovascular Events in Chronic Kidney Disease: A Prospective Cohort Study
    Stadler, Julia T.
    Borenich, Andrea
    Bisgaard, Line Stattau
    Bjergfelt, Sasha S.
    Vijayakumar, Sarunja
    Melholt, Line
    Emrich, Insa E.
    Hansen, Ditte
    Bro, Susanne
    Christoffersen, Christina
    Heine, Gunnar H.
    Marsche, Gunther
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2025, 45 (04) : 496 - 505
  • [47] Neuropeptide Y predicts cardiovascular events in chronic kidney disease patients: a cohort study
    Zoccali, Carmine
    D'Arrigo, Graziella
    Leonardis, Daniela
    Pizzini, Patrizia
    Postorino, Maurizio
    Tripepi, Giovanni
    Mallamaci, Francesca
    JOURNAL OF HYPERTENSION, 2019, 37 (07) : 1359 - 1365
  • [48] A longitudinal study on the incidence of cardiovascular events in a population of Northern Italy
    Bianco, E.
    Dei Cas, M.
    Bignotto, M.
    Morano, C.
    Rigoldi, C.
    Trevisi, G.
    Berra, C.
    Zermiani, P.
    Zuin, M.
    Paroni, R.
    Folli, F.
    Battezzati, P.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 125 - 126
  • [49] Association of morning hypertension with chronic kidney disease progression and cardiovascular events in patients with chronic kidney disease and hypertension
    Liu, Xiang
    Li, Fangming
    Zheng, Zhiyao
    Li, Gen
    Zhou, Huan
    Zhang, Ting
    Tang, Yi
    Qin, Wei
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2022, 32 (04) : 965 - 972
  • [50] Genetic Variants Associated with Chronic Kidney Disease in a Spanish Population
    Zuray Corredor
    Miguel Inácio da Silva Filho
    Lara Rodríguez-Ribera
    Antonia Velázquez
    Alba Hernández
    Calogerina Catalano
    Kari Hemminki
    Elisabeth Coll
    Irene Silva
    Juan Manuel Diaz
    José Ballarin
    Martí Vallés Prats
    Jordi Calabia Martínez
    Asta Försti
    Ricard Marcos
    Susana Pastor
    Scientific Reports, 10